跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DYMISTA 137 MICROGRAMOS/50 MICROGRAMOS/APLICACION SUSPENSION PARA PULVERIZACION NASAL - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
DYMISTA 137 MICROGRAMOS/50 MICROGRAMOS/APLICACION SUSPENSION PARA PULVERIZACION NASAL
Approved
STANDARD
DYMISTA 137 MICROGRAMOS/50 MICROGRAMOS/APLICACION SUSPENSION PARA PULVERIZACION NASAL
Meda Pharma
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Oct 1, 2020
Approval ID
1f69799a9b3fe340
Company
Meda Pharma
Type
Standard
Approval Details
Approval Id
1f69799a9b3fe340
Drug Cima Aemps Name
DYMISTA 137 MICROGRAMOS/50 MICROGRAMOS/APLICACION SUSPENSION PARA PULVERIZACION NASAL
Register Number
3400927563119IP
Holder Company Name
Meda Pharma
Marketing Company Name
Melyfarma S.L.
Authorization Date
2020-10-01
Dosage Form
SUSPENSIÓN PARA PULVERIZACIÓN NASAL
Dose
1 mg/g - 0,365 mg/g
Route Of Administration
VÍA NASAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Meda Pharma
Active Ingredients
AZELASTINA HIDROCLORURO
1 mg
FLUTICASONA PROPIONATO
0,365 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Oct 1, 2020
Approval ID
1f69799a9b3fe340
Type
Standard
Back to CIMA-AEMPS Approvals